dockets: FDA-2025-P-0394

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2025-P-0394 FDA Request that FDA determine whether the Reference Listed Drug (RLD), Sulfadiazine Tablets, 500 mg under New Drug Application (NDA) 004122 held by Eli Lilly and Co., was voluntarily withdrawn from commercial distribution or withdrawn from sale for safety or efficacy reasons. Nonrulemaking 2026-09-30T19:42:31Z 0b0000648693553a                     list_pull

Links from other tables